Physician profile
Dmitriy N Feldman
NPI 1568632859
$30,236.80
in general payments reported to CMS, 2019-2025
21 companies · $16K in 2025
The $16K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,271 · 2020: $647 · 2021: $853 · 2022: $1,084 · 2023: $1,786 · 2024: $4,047 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,664 · Food and Beverage: $5,654 · Travel and Lodging: $5,465 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,663.50 |
| Food and Beverage | $5,654.48 |
| Travel and Lodging | $5,464.60 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15,671.35 | 2021-2025 | Symplicity G3, Abre, Endurant Iis |
| Medtronic Vascular, INC. | $6,061.63 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $2,498.28 | 2024 | |
| Abbott Laboratories | $2,034.83 | 2019-2025 | Coroflow, Amplatzer Talisman, Amplatzer Amulet |
| Boston Scientific Corporation | $880.96 | 2019-2025 | Avvigo Guidance System, Rotapro |
| W. L. Gore & Associates, INC. | $600.00 | 2025 | Product In Development |
| Philips North America LLC | $530.59 | 2019-2024 | (6574) Coronary Other, (6366) Sync |
| Shockwave Medical, INC | $518.21 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Spectrawave, INC | $397.82 | 2024-2025 | Starlight Imaging Catheter, Hypervue Imaging System |
| Abiomed | $265.46 | 2021-2023 | Impella |
| Endologix LLC | $205.74 | 2025 | Torus Stent Graft System, Endocross Device |
| Edwards Lifesciences Corporation | $144.67 | 2024 | Sapien 3 Ultra Resilia |
| United Therapeutics Corporation | $100.00 | 2020 | |
| Atricure, INC. | $81.48 | 2023 | |
| Teleflex LLC | $64.16 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $62.00 | 2020-2024 | Repatha |
| Chiesi USA, INC. | $33.65 | 2023-2024 | Kengreal |
| Astrazeneca Pharmaceuticals Lp | $32.58 | 2022 | |
| Cardiva Medical, INC. | $27.59 | 2023 | Cardiva Vascade 6/7f Vcs |
| Scpharmaceuticals INC. | $25.80 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dmitriy Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.